- Catalogs
- Kamiya Biomedical Company LLC
- KAI-230 (R-2) SAFETY DATA SHEET (SDS)
KAI-230 (R-2) SAFETY DATA SHEET (SDS)
KAI-230 (R-2) SAFETY DATA SHEET (SDS)
Product Name: RF (Ver.2), R-2, Catalog #: KAI-230 (R-2). Intended for quantitative determination of human IgG rheumatoid factor antibodies in serum or plasma using an immunoturbidimetric in vitro assay. Manufacturer: KAMIYA BIOMEDICAL COMPANY, Seattle, WA, USA.
The product does not meet the criteria for classification as dangerous or hazardous. No hazard symbols, signal words, or precautionary statements are required.
The product is a mixture containing less than 0.1% Sodium Azide (CAS # 26628-22-8).
Inhalation: Move to fresh air and seek medical attention if breathing difficulties occur. Skin Contact: Wash thoroughly with water and seek medical attention if irritation occurs. Eye Contact: Rinse with water and seek medical attention. Ingestion: Rinse mouth, drink water, and seek medical attention without inducing vomiting.
No specific fire or explosion hazards. Use appropriate extinguishing media. Protective equipment may be necessary.
Wear protective equipment, avoid environmental contamination, and clean up with absorbent materials. Dispose of waste properly.
Avoid contact with skin, eyes, or clothing. Store between +2 and +8 degrees C. Sodium Azide can form explosive compounds with metals.
Use protective glasses, gloves, and clothing. No respiratory protection is required.
Liquid state, white and turbid, odorless, miscible in water, not self-igniting.
Stable under recommended conditions. Sodium Azide can react with metals to form explosive compounds.
Contains low concentration of Sodium Azide, which is toxic in pure form. Target organs include the blood and cardiovascular systems.
Sodium Azide is harmful to aquatic life with long-lasting effects.
Dispose of in accordance with local regulations. Do not release into water systems.
Non-hazardous for transport.
Users should verify regulatory information for their region.
For in vitro use only. Information is believed accurate but not exhaustive. Users should determine suitability and safety precautions.
Catalog excerpts
Synonyms: Rheumatoid Factor (Version 2), R-1 Intended Use: For the quantitative determination of human IgG rheumatoid factor antibodies in patient serum or plasma (citric acid, EDTA, or lithium heparin) based on immunoturbidimetric in vitro assay. Manufacturer: KAMIYA BIOMEDICAL COMPANY Website: www.k-assay.com Address: 12779 Gateway Drive KAMIYA BIOMEDICAL COMPANY SDS for KAI-230 (R-2) Rev. 2020-09-08 Page 1 of 4
Open the catalog to page 1
6. ACCIDENTAL RELEASE MEASURES
Open the catalog to page 2
This product is a mixture that contains a very low concentration of the following substance. Here are details for the substance in pure form. Regulatory information with regard to this preparation in your country or region should be examined on your own responsibility. KAMIYA BIOMEDICAL COMPANY SDS for KAI-230 (R-2) Rev. 2020-09-08 Page 3 of 4
Open the catalog to page 3
16. OTHER INFORMATION / DISCLAIMER This product is for in vitro use only. It is not to be used internally in humans or animals. The information, data, and recommendations contained herein are based upon information believed by KAMIYA BIOMEDICAL COMPANY (KBC) to be accurate, but does not purport to be all-inclusive and shall be used only as a guide. KBC neither warrants the accuracy of this information nor assumes any legal responsibility in connection with its dissemination. KBC shall not be held liable for any damage resulting from handling or from contact with the above product. It is the user's...
Open the catalog to page 4All Kamiya Biomedical Company LLC catalogs and technical brochures
Assay Flyer4 Pages
